Skip to content
Search

Latest Stories

Prof Ryan Donnelly awarded prestigious RPS Harrison Memorial Medal 2024

Prof Ryan Donnelly awarded prestigious RPS Harrison Memorial Medal 2024
RPS HMM winner Professor Donnelly's work has secured £30M+ funding through his pioneering work in developing advanced polymeric drug delivery systems

Professor Ryan Donnelly, esteemed for his groundbreaking contributions to pharmaceutical science, has been awarded the prestigious Royal Pharmaceutical Society (RPS) Harrison Memorial Medal for 2024.

This distinguished accolade, presented in honour of the renowned pharmaceutical chemist Col EF Harrison, serves as a testament to Professor Donnelly's exceptional achievements.


Currently holding the position of Chair in Pharmaceutical Technology at Queen’s University Belfast’s School of Pharmacy and Director of Research, Professor Donnelly has garnered acclaim for his pioneering work in developing advanced polymeric drug delivery systems.

Specialising in transdermal and intradermal drug delivery methodologies, his research aims at optimising patient outcomes through innovative pharmaceutical technologies.

Collaborating closely with leading pharmaceutical companies, Professor Donnelly has led the charge in creating novel microneedle technologies.

His efforts have attracted substantial funding, exceeding £30 million, and have resulted in an extensive publication portfolio comprising over 1000 peer-reviewed works.

Moreover, Professor Donnelly's leadership has fostered a diverse and dynamic research team comprising individuals from 15 different countries.

His expertise has been recognised on a global scale, evidenced by his frequent invitations to speak at prestigious national and international conferences.

In addition, Professor Donnelly has been the recipient of the International Association for Pharmaceutical Technology Research Award for Outstanding Achievements in the Pharmaceutical Sciences and the Kydonieus Foundation Transdermal Delivery Award, both bestowed upon him in 2024.

Expressing his gratitude for the recognition, Professor Donnelly remarked, "I am delighted to receive this great honor from RPS."

"As a pharmacist, my work has always focused on harnessing the pharmaceutical sciences to develop drug and vaccine delivery systems that can enhance therapeutic outcomes for patients."

Commending Professor Donnelly's contributions, Professor Parastou Donyai, RPS Chief Scientist, emphasised his unparalleled leadership in the field of drug delivery research and said:

"It is a real pleasure to announce Professor Ryan Donnelly as the 2024 RPS Harrison Medal Winner."

"His novel inventions have potential for genuine impact, and his publication record, substantial research funding, and investment in developing others attest to his authority and distinction."

"Professor Donelly is a world leader in the field of drug delivery" and "is a credit to pharmaceutical science and the whole of the profession of pharmacy," he further added.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less